How Long Should You Continue Bisphosphonate Treatment for Osteoporosis? - Frankly Speaking Ep 225

<p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;"> Credits: 0.25 AMA PRA Category 1 Credit™</p> <p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;">  </p> <p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;"> CME/CE Information and Claim Credit: <a href= "https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-208" target="_blank" rel= "noopener">https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-225</a></p> <p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;">  </p> <p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;"> Overview: Join us for this episode as we review the recently published (Dec. 2020) cohort study in JAMA on using bisphosphonates to prevent hip fractures. We will review the utility of bisphosphonates after 5 years and how to discuss their risks and benefits with patients.</p> <p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;">  </p> <p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;"> Episode resource links:</p> <ul> <li style="font-family: Calibri; font-size: 11pt;"> JAMA.2020;3(12):e2025190.doi:10.1001/jamanetworkopen.2020.25190</li> <li style="font-family: Calibri; font-size: 11pt;">JAMA. 2018;319(24):2521-2531. doi:10.1001/jama.2018.7498</li> <li style="font-family: Calibri; font-size: 11pt;"><a href= "https://www.sheffield.ac.uk/FRAX/tool.aspx?country=9">https://www.sheffield.ac.uk/FRAX/tool.aspx?country=9</a></li> </ul> <p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;"> Guest: Robert A. Baldor MD, FAAFP</p> <p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;">  </p> <p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;"> Music Credit: Richard Onorato</p>